TRAW Traws Pharma, Inc. - Common Stock
$0,55
Prix · Aoû 19, 2026
Données fondamentales au Aoû 14, 2026
Fourchette 52 semaines
$0–$3
4% of range
Note des analystes
HOLD
7 analysts
Objectif de cours
$1
+81% upside
P/E (TTM)
1.4
ROE
—
Marge nette
—
TRAW Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.55
Capitalisation Boursière
—
P/E (TTM)
1.4
BPA (TTM)
$0.82
Revenus (TTM)
$3M
Rendement div.
—
ROE
—
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $3
TRAW Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$3M
2016-12-31
→
2025-12-31
BPA
$0.82
2020-12-31
→
2025-12-31
Flux de trésorerie libre
—
2019-12-31
→
2019-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
TRAW
Médiane des pairs
P/E (TTM)
1.4
23.4
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
TRAW
Médiane des pairs
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
TRAW
Médiane des pairs
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
TRAW
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
1134.5%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
131.1%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
64.6%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
TRAW
Médiane des pairs
TRAW Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
VENTE
7 analystes
- Achat fort 0 0,0%
- Achat 0 0,0%
- Conserver 4 57,1%
- Vente 1 14,3%
- Vente forte 2 28,6%
Objectif de cours à 12 mois
1 analystes · 2026-08-19
Bas
$1.00
Haut
$1.00
Objectif médian
$1.00
+80,7%
Objectif moyen
$1.00
+80,7%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
18.0%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.53 | $-0.75 | 0.22% |
| 31 décembre 2025 | $0.63 | $-1.25 | 1.9% |
| 31 décembre 2024 | $95.66 | $-9.74 | 105.4% |
| 30 septembre 2024 | $-8.81 | $-6.25 | -2.6% |
| 31 décembre 2023 | $-4.75 | $-6.46 | 1.7% |
| 30 septembre 2023 | $-5.75 | $-7.39 | 1.6% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| TRAW | — | 1.4 | 1134.5% | — | — | — |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | — |
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| CNSP | — | -0.1 | — | — | — | — |
| CURX | $9M | -1.9 | — | — | -73.3% | — |
| SNES | $11M | -1.1 | 19.6% | -287.4% | -77.2% | 62.5% |
| SNOA | $4M | -1.1 | 36.7% | -16.3% | -92.3% | 38.0% |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $226.0K | $226.0K | $226.0K | $226.0K | $231.0K | $2M | $1M | $787.0K | $6M | $11M | $800.0K | |
| R&D Expense | · | · | $11M | $11M | $7M | $17M | $16M | $17M | $19M | $20M | $26M | $49M | |
| SG&A Expense | $9M | $12M | $9M | $8M | $9M | $8M | $8M | $8M | $7M | $9M | $10M | $15M | |
| Operating Expenses | $21M | $143M | $21M | $20M | $17M | $25M | $24M | $25M | $27M | $29M | $35M | $65M | |
| Operating Income | $-18M | $-142M | $-20M | $-20M | $-16M | $-25M | $-22M | $-23M | $-26M | $-24M | $-24M | $-64M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Interest Income | $455.0K | $510.0K | $1M | $651.0K | · | · | · | · | · | · | · | · | |
| Other Non-op | $478.0K | $289.0K | $1M | $663.0K | $12.0K | $48.0K | $143.0K | $1M | $30.0K | $62.0K | $-35.0K | $-52.0K | |
| Pretax Income | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-21M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| Income Tax | · | · | · | · | · | $4.0K | $10.0K | $-124.0K | $13.0K | $14.0K | $16.0K | $19.0K | |
| Net Income | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-22M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| EPS (Basic) | $0.83 | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 | · | · | · | · | · | · | |
| EPS (Diluted) | $0.82 | $-35.21 | $-22.57 | $-0.91 | $-0.96 | $-2.17 | · | · | · | · | · | · | |
| Shares (Basic) | 8,228,169 | 1,552,685 | 839,554 | 20,908,235 | 16,832,198 | 11,602,391 | · | · | · | · | · | · | |
| Shares (Diluted) | 8,376,380 | 1,552,685 | 839,554 | 20,908,235 | 16,832,198 | 11,602,391 | · | · | · | · | · | · | |
| EBITDA | · | · | · | · | · | · | $-22M | $-23M | · | $-24M | $-24M | $-63M |
Bilan 22
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $21M | $39M | · | · | · | · | · | $21M | $20M | $44M | |
| Receivables | $4M | $2M | $18.0K | $29.0K | $28.0K | $37.0K | $98.0K | $35.0K | $59.0K | $31.0K | $2M | $132.0K | |
| Prepaid Expense | $365.0K | $2M | $2M | $561.0K | $332.0K | $722.0K | $650.0K | $760.0K | $820.0K | $2M | $2M | $3M | |
| Other Current Assets | $89.0K | $178.0K | $401.0K | $40.0K | $35.0K | $180.0K | $140.0K | $68.0K | $77.0K | $73.0K | $195.0K | $255.0K | |
| Current Assets | $8M | $25M | $23M | $39M | $55M | $20M | $23M | $18M | $5M | $23M | $23M | $47M | |
| PP&E (Net) | $7.0K | $10.0K | $22.0K | $24.0K | $38.0K | $52.0K | $50.0K | $9.0K | $64.0K | $152.0K | $248.0K | $420.0K | |
| PP&E (Gross) | · | · | $84.0K | $70.0K | $70.0K | $70.0K | $2M | $2M | $2M | $2M | $2M | $3M | |
| Accum. Depreciation | $77.0K | $74.0K | $62.0K | $46.0K | $32.0K | $18.0K | $2M | $2M | $2M | $2M | $2M | $2M | |
| Intangibles | $3M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $104.0K | $1.0K | $1.0K | $1.0K | $10.0K | $150.0K | $150.0K | $149.0K | $12.0K | $12.0K | $12.0K | $12.0K | |
| Total Assets | $11M | $25M | $23M | $39M | $55M | $20M | $24M | $18M | $5M | $23M | $23M | $47M | |
| Accounts Payable | $6M | $8M | $6M | $4M | $3M | $5M | $4M | $4M | $6M | $5M | $3M | $4M | |
| Accrued Liabilities | $5M | $3M | $3M | $4M | $3M | $5M | $4M | $4M | · | · | · | · | |
| Current Liabilities | $11M | $12M | $9M | $8M | $6M | $10M | $8M | $8M | $10M | $10M | $8M | $10M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1.0K | |
| Total Liabilities | $11M | $57M | $12M | $11M | $9M | $14M | $12M | $13M | $16M | $18M | $13M | $24M | |
| Common Stock | $90.0K | $36.0K | $9.0K | $209.0K | $209.0K | $124.0K | $1M | $57.0K | $8.0K | $68.0K | $25.0K | $217.0K | |
| Retained Earnings | $-640M | $-649M | $-483M | $-464M | $-445M | $-429M | $-403M | $-382M | $-362M | $-338M | $-319M | $-295M | |
| AOCI | $6.0K | $-42.0K | $-23.0K | $-33.0K | $-14.0K | $14.0K | $-18.0K | $-12.0K | $3.0K | $-31.0K | $-22.0K | $-13.0K | |
| Stockholders' Equity | $-629.0K | $-32M | $11M | $28M | $46M | $6M | $12M | $5M | $-12M | $4M | $10M | $23M | |
| Liabilities + Equity | $11M | $25M | $23M | $39M | $55M | $20M | $24M | $18M | $5M | $23M | $23M | $47M | |
| Shares Outstanding | 9,067,774 | 3,650,731 | 840,251 | 20,925,992 | 20,895,563 | 12,396,219 | 111,167,352 | 5,674,220 | 718,078 | 6,759,895 | 2,546,419 | 21,703,173 |
Flux de trésorerie 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $61.0K | $12.0K | $16.0K | $14.0K | $14.0K | $13.0K | $14.0K | $55.0K | $88.0K | $96.0K | $150.0K | $434.0K | |
| Stock-based Comp | $728.0K | $1M | $1M | $1M | $576.0K | $369.0K | $1M | $1M | $2M | $4M | $4M | $5M | |
| Deferred Tax | · | · | · | · | · | · | · | $-137.0K | · | $0 | $0 | $0 | |
| Amort. of Intangibles | $58.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $-390.0K | $-3M | · | $-171.0K | $-11M | $532.0K | |
| Operating Cash Flow | $-18M | $-30M | $-18M | $-16M | $-19M | $-23M | $-21M | $-23M | $-24M | $-16M | $-31M | $-58M | |
| CapEx | $3M | $4M | $14.0K | · | · | $15.0K | $55.0K | · | · | · | · | $228.0K | |
| Investing Cash Flow | $-3M | $-4M | $-14.0K | · | · | $-15.0K | $-55.0K | · | · | · | · | · | |
| Stock Issued | $6M | · | · | · | $55M | $9M | $22M | $35M | · | · | $7M | · | |
| Net Stock Activity | · | · | · | · | · | · | $22M | · | · | · | $7M | · | |
| Financing Cash Flow | $3M | $34M | · | · | $56M | $19M | $27M | $36M | $6M | $17M | · | · | |
| Net Change in Cash | $-18M | $517.0K | $-18M | $-16M | $36M | $-4M | $6M | $13M | $-17M | $2M | $-24M | $-16M | |
| Free Cash Flow | · | · | · | · | · | · | $-21M | · | · | · | · | $-58M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-58M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | -994.0% | -1895.9% | · | -427.4% | -209.2% | -7968.0% | |
| Net Margin | · | · | · | · | · | · | -985.0% | -1675.3% | · | -354.6% | -209.3% | -7960.3% | |
| Pretax Margin | · | · | · | · | · | · | -984.6% | -1672.1% | · | -354.4% | -209.6% | -7972.0% | |
| EBITDA Margin | · | · | · | · | · | · | -993.4% | -1891.5% | · | -425.7% | -207.9% | -7913.8% | |
| ROA | · | · | · | · | · | · | -103.4% | -179.7% | · | -84.3% | -67.8% | -83.5% | |
| ROE | · | · | · | · | · | · | -777.3% | 652.7% | · | -274.9% | -146.4% | -123.5% | |
| ROIC | · | · | · | · | · | · | -187.6% | -429.6% | · | -552.0% | -239.6% | -280.3% |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | · | 2.8 | 2.1 | · | 2.3 | 3.0 | 4.6 | |
| Quick Ratio | · | · | · | · | · | · | 0.0 | 0.0 | · | 2.1 | 2.8 | 4.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -31872.0 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.2 | 0.3 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 32.8 | 26.1 | · | 7.2 | 14.0 | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 1134.5% | 0.00% | 0.00% | 0.00% | -2.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 131.1% | 0.00% | -0.73% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 64.6% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $226.0K | $226.0K | $226.0K | $226.0K | $231.0K | $2M | $1M | $787.0K | $6M | $11M | $800.0K | |
| Net Income TTM | $9M | $-167M | $-19M | $-19M | $-16M | $-25M | $-22M | $-21M | $-24M | $-20M | $-24M | $-64M | |
| Market Cap | · | · | · | · | · | · | $15.84B | $4.49B | · | $86.32B | $1.38T | $4.02T | |
| P/E | 1.4 | -0.3 | -0.8 | -17.9 | -66.4 | -81.2 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | 7256.7 | 3656.1 | · | 15563.5 | 120030.2 | 5020554.3 | |
| P/B | · | · | · | · | · | · | 1368.7 | 833.4 | · | 20087.4 | 137369.3 | 176562.5 | |
| P / Tangible Book | · | · | 36.9 | 12.0 | 28.9 | 5307.3 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | · | · | -760.5 | -197.8 | · | -5458.5 | -44019.0 | -69671.9 | |
| P / FCF | · | · | · | · | · | · | -758.5 | · | · | · | · | -69397.4 | |
| Earnings Yield | 72.6% | -396.5% | -120.4% | -5.6% | -1.5% | -1.2% | · | · | · | · | · | · |
Compte de résultat 12
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $3M | $57.0K | $56.0K | $57.0K | $57.0K | $56.0K | $56.0K | $57.0K | $57.0K | $56.0K | $56.0K | $57.0K | |
| R&D Expense | $1M | $5M | · | · | $2M | $3M | · | · | · | $2M | · | $2M | $2M | $4M | $4M | $4M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $3M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $7M | $7M | $4M | $4M | $5M | $5M | $9M | $123M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | |
| Operating Income | $-3M | $-7M | $-7M | $-4M | $-1M | $-5M | $-5M | $-9M | $-123M | $-5M | $-4M | $-5M | $-5M | $-6M | $-6M | $-6M | |
| Other Non-op | $-94.0K | $-2.0K | $14.0K | $96.0K | $188.0K | $180.0K | $-206.0K | $61.0K | $205.0K | $229.0K | $278.0K | $350.0K | $360.0K | $362.0K | $314.0K | $243.0K | |
| Net Income | $-3M | $-7M | $-7M | $-4M | $-915.0K | $21M | $-30M | $-8M | $-123M | $-5M | $-4M | $-5M | $-4M | $-6M | $-5M | $-5M | |
| EPS (Basic) | $-0.16 | $-0.53 | $-0.89 | $-0.34 | $-0.11 | $2.17 | $-7.28 | $-1.49 | $-20.52 | $-5.92 | $-16.45 | $-5.64 | $-0.20 | $-0.28 | $-0.26 | $-0.26 | |
| EPS (Diluted) | $-0.16 | $-0.53 | $-0.82 | $-0.34 | $-0.11 | $2.09 | $-7.28 | $-1.49 | $-20.52 | $-5.92 | $-16.45 | $-5.64 | $-0.20 | $-0.28 | $-0.26 | $-0.26 | |
| Shares (Basic) | 15,864,041 | 10,640,625 | -13,377,520 | 8,818,859 | 5,820,903 | 6,965,927 | -1,263,013 | 961,530 | 1,012,430 | 841,738 | -41,940,500 | 840,117 | 20,979,766 | 20,960,171 | -41,815,343 | 20,915,408 | |
| Shares (Diluted) | 15,864,041 | 10,640,625 | -13,478,507 | 8,818,859 | 5,820,903 | 7,215,125 | -1,263,013 | 961,530 | 1,012,430 | 841,738 | -41,940,500 | 840,117 | 20,979,766 | 20,960,171 | -41,815,343 | 20,915,408 | |
| EBITDA | $-3M | $-7M | · | $-4M | $-1M | $-5M | · | $-9M | $-123M | $-5M | · | $-5M | $-5M | $-6M | · | $-6M |
Bilan 20
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $3M | $2M | $4M | $2M | $1M | $2M | $2M | $2M | $18.0K | $18.0K | $18.0K | $18.0K | $17.0K | $17.0K | $29.0K | $28.0K | |
| Prepaid Expense | $553.0K | $845.0K | $365.0K | $1M | $966.0K | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $704.0K | $802.0K | $561.0K | $1M | |
| Other Current Assets | $93.0K | $138.0K | $89.0K | $92.0K | $124.0K | $183.0K | $178.0K | $347.0K | $583.0K | $263.0K | $401.0K | $303.0K | $264.0K | $68.0K | $40.0K | $303.0K | |
| Current Assets | $9M | $6M | $8M | $10M | $15M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| PP&E (Net) | $5.0K | $6.0K | $7.0K | $7.0K | $8.0K | $9.0K | $10.0K | $12.0K | $14.0K | $18.0K | $22.0K | $26.0K | $17.0K | $21.0K | $24.0K | $28.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $84.0K | $84.0K | $84.0K | · | $84.0K | $70.0K | $70.0K | · | $70.0K | |
| Accum. Depreciation | · | · | $77.0K | $77.0K | $76.0K | $75.0K | $74.0K | $72.0K | $70.0K | $66.0K | $62.0K | $58.0K | $53.0K | $49.0K | $46.0K | $42.0K | |
| Intangibles | $2M | $2M | $3M | $3M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.0K | $1.0K | $104.0K | $240.0K | $244.0K | $198.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Total Assets | $11M | $8M | $11M | $12M | $16M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| Accounts Payable | $6M | $8M | $6M | $5M | $5M | $8M | $8M | $5M | $6M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | |
| Accrued Liabilities | $3M | $6M | $5M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | |
| Current Liabilities | $10M | $13M | $11M | $8M | $7M | $10M | $12M | $8M | $10M | $9M | $9M | $10M | $9M | $9M | $8M | $7M | |
| Total Liabilities | $10M | $13M | $11M | $8M | $7M | $13M | $57M | $11M | $13M | $12M | $12M | $13M | $12M | $12M | $11M | $10M | |
| Common Stock | $152.0K | $101.0K | $90.0K | $71.0K | $71.0K | $50.0K | $36.0K | $30.0K | $253.0K | $211.0K | $9.0K | $210.0K | $210.0K | $210.0K | $209.0K | $209.0K | |
| Retained Earnings | $-650M | $-647M | $-640M | $-633M | $-629M | $-628M | $-649M | $-619M | $-611M | $-488M | $-483M | $-478M | $-474M | $-469M | $-464M | $-458M | |
| AOCI | $-5.0K | $-2.0K | $6.0K | $6.0K | $9.0K | $-19.0K | $-42.0K | $-33.0K | $-33.0K | $-30.0K | $-23.0K | $-30.0K | $-28.0K | $-27.0K | $-33.0K | $-61.0K | |
| Stockholders' Equity | $2M | $-5M | $-629.0K | $5M | $8M | $6M | $-32M | $-2M | $-106M | $6M | $11M | $15M | $19M | $23M | $28M | $33M | |
| Liabilities + Equity | $11M | $8M | $11M | $12M | $16M | $19M | $25M | $9M | $19M | $18M | $23M | $27M | $30M | $35M | $39M | $44M | |
| Shares Outstanding | 15,264,812 | 10,162,587 | 9,067,774 | 7,131,151 | 7,069,148 | 5,075,390 | 3,650,731 | 3,025,554 | 25,306,509 | 21,085,935 | 840,251 | 21,003,409 | 20,977,625 | 20,969,559 | 20,925,992 | 20,925,992 |
Flux de trésorerie 11
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $44.0K | $44.0K | $44.0K | $15.0K | $1.0K | $1.0K | $2.0K | $2.0K | $4.0K | $4.0K | $4.0K | $5.0K | $4.0K | $3.0K | $4.0K | $3.0K | |
| Stock-based Comp | $816.0K | $634.0K | $327.0K | $135.0K | $105.0K | $161.0K | $334.0K | $343.0K | $380.0K | $333.0K | $332.0K | $360.0K | $273.0K | $336.0K | $330.0K | $305.0K | |
| Amort. of Intangibles | $43.0K | $43.0K | $44.0K | $14.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $4M | · | · | · | $-27M | · | · | · | $222.0K | · | · | · | $893.0K | · | · | |
| Operating Cash Flow | $-8M | $-3M | $-3M | $-4M | $-6M | $-5M | $-4M | $-11M | $-10M | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | · | · | $0 | · | · | · | · | · | |
| Investing Cash Flow | · | · | $0 | · | · | · | $0 | $0 | · | · | $0 | · | · | · | · | · | |
| Stock Issued | $120.0K | $2M | $2M | $116.0K | $3M | $122.0K | · | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $2M | · | · | · | $122.0K | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $9M | $2M | $158.0K | $-62.0K | $3M | $13.0K | $20M | $0 | · | · | · | · | · | · | · | · | |
| Net Change in Cash | $2M | $-687.0K | $-3M | $-7M | $-3M | $-5M | $16M | $-11M | $496.0K | $-4M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M |
Rentabilité 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -45.7% | -9128.1% | · | -14975.4% | -216400.0% | -9307.1% | · | -8928.1% | -8087.7% | -10958.9% | · | -9896.5% | |
| Net Margin | · | · | · | · | -33.5% | 37701.8% | · | -14868.4% | -216040.3% | -8898.2% | · | -8314.0% | -7456.1% | -10312.5% | · | -9470.2% | |
| EBITDA Margin | · | · | · | · | -45.7% | -9126.3% | · | -14975.4% | -216400.0% | -9300.0% | · | -8928.1% | -8087.7% | -10953.6% | · | -9896.5% | |
| ROA | -22.6% | -52.2% | · | -37.1% | -5.3% | 115.4% | · | -47.1% | -501.1% | -18.7% | · | -13.4% | -10.8% | -13.4% | · | -10.4% | |
| ROE | -61.4% | -2063.0% | · | -315.4% | 1.9% | 357.7% | · | -135.8% | 284.3% | -34.5% | · | -19.8% | -14.8% | -17.7% | · | -13.0% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.4 | · | 1.2 | 2.1 | 1.8 | · | 1.1 | 1.9 | 1.9 | · | 2.8 | 3.5 | 3.8 | · | 6.0 | |
| Quick Ratio | 0.4 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.3 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.2 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | 4.1 | 0.1 | · | 0.1 | 3.3 | 3.2 | · | 2.5 | 2.5 | 2.5 | · | 2.0 |
Valorisation (TTM) 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | · | $3M | $3M | $227.0K | · | $227.0K | $227.0K | $226.0K | · | $227.0K | $227.0K | $226.0K | · | $227.0K | |
| Net Income TTM | $-15M | $10M | · | $8M | $-111M | $-115M | · | $-141M | $-137M | $-20M | · | $-20M | $-19M | $-19M | · | $-17M | |
| Market Cap | $13M | $19M | · | $13M | $10M | $12M | · | $18M | $285M | $532M | · | $373M | $619M | $383M | · | $460M | |
| P/E | -0.7 | 1.6 | · | 12.3 | -0.1 | -0.1 | · | -0.2 | -0.3 | -2.1 | · | -2.8 | -31.7 | -19.6 | · | -25.3 | |
| P/S | 4.4 | 6.4 | · | 4.5 | 3.6 | 51.4 | · | 78.4 | 1254.2 | 2355.8 | · | 1642.3 | 2726.2 | 1693.3 | · | 2028.1 | |
| P/B | 7.6 | -3.5 | · | 2.9 | 1.3 | 1.9 | · | -8.8 | -2.7 | 88.5 | · | 25.7 | 32.7 | 16.7 | · | 13.8 | |
| P / Tangible Book | · | · | · | 6.7 | 1.3 | 1.9 | · | · | · | 88.5 | · | 25.7 | 32.7 | 16.7 | · | 13.8 | |
| P / Cash Flow | · | -7.2 | · | · | · | -2.1 | · | · | · | -120.3 | · | · | · | -84.2 | · | · | |
| Earnings Yield | -135.7% | 60.7% | · | 8.1% | -1353.4% | -1123.5% | · | -570.9% | -286.9% | -47.7% | · | -35.9% | -3.1% | -5.1% | · | -4.0% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $3M | $226.0K | $226.0K | $226.0K | $226.0K |
| Résultat net | $9M | $-167M | $-19M | $-19M | $-16M |
| BPA dilué | $0.82 | $-35.21 | $-22.57 | $-0.91 | $-0.96 |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 36 déclarants · $5.0M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 17 (+3 vs T. préc.) | 6 (-1 vs T. préc.) | 7 (+4 vs T. préc.) | 8 (+5 vs T. préc.) | +2.4M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $1 014 709 | 1 203 260 | 20,44% | Actions |
| Ally Bridge Group (NY) LLC | $663 033 | 786 236 | 13,36% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $615 609 | 730 000 | 12,40% | Actions |
| ADAR1 Capital Management, LLC | $504 065 | 597 729 | 10,15% | Actions |
| Lynx1 Capital Management LP | $471 801 | 559 470 | 9,50% | Actions |
| Ikarian Capital, LLC | $403 217 | 478 142 | 8,12% | Actions |
| SPHERA FUNDS MANAGEMENT LTD. | $336 043 | 398 486 | 6,77% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $278 231 | 330 049 | 5,60% | Actions |
| Alyeska Investment Group, L.P. | $138 618 | 164 376 | 2,79% | Actions |
| BOOTHBAY FUND MANAGEMENT, LLC | $112 948 | 133 936 | 2,28% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $90 305 | 107 084 | 1,82% | Actions |
| Kynam Capital Management, LP | $71 175 | 84 400 | 1,43% | Actions |
| Dauntless Investment Group, LLC | $67 948 | 80 574 | 1,37% | Actions |
| JANE STREET GROUP, LLC | $59 315 | 70 337 | 1,19% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $45 953 | 54 511 | 0,93% | Actions |
| NORTHERN TRUST CORP | $31 581 | 37 449 | 0,64% | Actions |
| STATE STREET CORP | $21 759 | 25 802 | 0,44% | Actions |
| XTX Topco Ltd | $15 257 | 18 092 | 0,31% | Actions |
| BlackRock, Inc. | $8 383 | 9 941 | 0,17% | Actions |
| Tower Research Capital LLC (TRC) | $4 336 | 5 142 | 0,09% | Actions |
| HUNTINGTON NATIONAL BANK | $3 943 | 4 676 | 0,08% | Actions |
| UBS Group AG | $2 217 | 2 630 | 0,04% | Actions |
| BARCLAYS PLC | $1 642 | 1 947 | 0,03% | Actions |
| SBI Securities Co., Ltd. | $1 451 | 1 721 | 0,03% | Actions |
| Federation des caisses Desjardins du Quebec | $414 | 500 | 0,01% | Actions |
| VANGUARD GROUP INC | $296 | 262 | 0,01% | Actions |
| Vanguard Global Advisers, LLC | $221 | 262 | 0,00% | Actions |
| HRT FINANCIAL LP | $76 | 91 220 | 0,00% | Actions |
| SG Americas Securities, LLC | $12 | 14 524 | 0,00% | Actions |
| Virtu Financial LLC | $11 | 12 579 | 0,00% | Actions |
| Cassaday & Co Wealth Management LLC | $6 | 6 | 0,00% | Actions |
| HARBOUR INVESTMENTS, INC. | $4 | 5 | 0,00% | Actions |
| Integrated Wealth Concepts LLC | $2 | 2 | 0,00% | Actions |
| MORGAN STANLEY | $2 | 2 | 0,00% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $2 | 2 | 0,00% | Actions |
| FMR LLC | $2 | 2 | 0,00% | Actions |
Initiés de la société 33 initiés · 15 dirigeants · 17 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Iain D. Dukes | Chief Executive Officer | 9 juillet 2026 A | 134 187 | 0 | 0 | $0 |
| Ramesh Kumar | Chief Executive Officer | 26 juillet 2018 A | 102 227 | 0 | 0 | $0 |
| Charles Nolan Parker | Chief Financial Officer | 9 juillet 2026 A | — | 0 | 0 | $0 |
| Mark Patrick Guerin | COO and CFO | 10 juin 2022 A | 145 213 | 0 | 0 | $0 |
| Ajay Bansal | Chief Financial Officer | 26 janvier 2016 A | 43 846 | 0 | 0 | $0 |
| Steven M Fruchtman | President, Chief Executive Off | 7 février 2022 A | 18 130 | 0 | 0 | $0 |
| Thomas J Mckearn | President, R&D | 26 janvier 2016 A | 3 333 | 0 | 0 | $0 |
| Nikolay Savchuk | Chief Operating Officer | 9 juillet 2026 A | 134 187 | 0 | 0 | $0 |
| Robert Redfield | Chief Medical Officer | 9 juillet 2026 A | 97 500 | 0 | 0 | $0 |
| Charles David Pauza | Chief Science Officer Virology | 9 juillet 2026 A | 97 500 | 0 | 0 | $0 |
| Mark S. Gelder MD | Chief Medical Officer | 7 février 2022 A | 2 381 | 0 | 0 | $0 |
| Abraham N. Oler | SVP Corp Dev & Gen Counsel | 7 février 2022 A | 24 514 | 0 | 0 | $0 |
| Richard Charles Woodman | Chief Medical Officer | 9 juillet 2020 A | — | 0 | 0 | $0 |
| Manoj Maniar | SVP - Product Development | 9 juillet 2020 A | 50 | 0 | 0 | $0 |
| James Altland | SVP, Finance & Corp. Develop. | 20 décembre 2013 A | 10 000 | 0 | 0 | $0 |
| Trafford Clarke | Administrateur | 9 juillet 2026 A | — | 0 | 0 | $0 |
| Mary Teresa Shoemaker | Administrateur | 9 juillet 2026 A | 50 735 | 0 | 0 | $0 |
| John Harold Leaman | Administrateur | 9 juillet 2026 A | — | 0 | 0 | $0 |
| Werner Cautreels | Administrateur | 9 juillet 2026 A | 109 222 | 0 | 0 | $0 |
| Jack E Stover | Administrateur | 9 juillet 2026 A | 6 165 | 0 | 0 | $0 |
| Luba Greenwood | Administrateur | 16 septembre 2024 A | — | 0 | 0 | $0 |
| James J Marino | Administrateur | 28 septembre 2021 P | 21 334 | 0 | 0 | $0 |
| Viren Mehta | Administrateur | 30 juillet 2021 A | 250 857 | 0 | 0 | $0 |
| Jerome Groopman | Administrateur | 30 juillet 2021 A | 10 001 | 0 | 0 | $0 |
| Premkumar E Reddy | Administrateur | 27 août 2020 S | 16 683 | 0 | 0 | $0 |
| Michael B Hoffman | Administrateur | 27 août 2020 S | 0 | 0 | 0 | $0 |
| Henry S Bienen | Administrateur | 29 mai 2018 P | 22 724 | 0 | 0 | $0 |
| Anne Vanlent | Administrateur | 15 juin 2015 A | — | 0 | 0 | $0 |
| TPAV, LLC | Détenteur de 10% | 29 décembre 2024 P | — | 0 | 0 | $0 |
| TYNDALL CAPITAL PARTNERS L P | Détenteur de 10% | 24 septembre 2019 S | 616 389 | 0 | 0 | $0 |
| 683 Capital Management, LLC | Détenteur de 10% | 27 avril 2018 P | 14 503 169 | 0 | 0 | $0 |
| Baxter Healthcare SA | Détenteur de 10% | 6 mai 2015 J | 0 | 0 | 0 | $0 |
| Michael & Jane Hoffman 2013 Descendants | Détenteur de 10% | 21 février 2014 P | 4 518 275 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 5 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC ×4 dépôts | 5 mai 2026 | 11,90% | Amendement | — | SEC |
| Viriom, Inc., Nikolay Savchuk, Iain D. Dukes | 8 avril 2024 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
| 683 Capital Partners, LP, 683 Capital Management, LLC, Ari Zweiman ×5 dépôts | 19 février 2020 | — | Dépôt initial | — | SEC |
| Michael B. Hoffman, Michael and Jane Hoffman 2018 Descendants Trust ×3 dépôts | 27 juillet 2018 | — | Dépôt initial | Investissement passif | SEC |
| E. Premkumar Reddy ×2 dépôts | 26 février 2018 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 2 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.